+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UK Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report by Product (System, Consumables), By Modality (Slow Continuous Ultra Filtration, Continuous Venovenous Hemofiltration), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 300 Pages
  • August 2024
  • Region: United Kingdom
  • Grand View Research
  • ID: 5998909

UK Continuous Renal Replacement Therapy Market Growth & Trends

The UK continuous renal replacement therapy market size is anticipated to reach USD 131.7 million by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030. The market is driven by numerous factors such as technological advancements such as innovations in design, materials, and manufacturing processes. These advancements have improved the safety, efficiency, and efficacy of CRRT treatments.

One of the most significant advancements in CRRT technology is the development of faster and more efficient filtration systems. New membrane technologies, such as hollow-fiber membranes and nanofiltration, have increased filtration rates and reduced treatment time. This means that patients can receive more effective treatment while minimizing the risk of complications like hemolysis and bleeding. Further, new tubing materials, such as heparin-coated lines, have minimized blood trauma and reduced the risk of complications like hemolysis. This is particularly important in patients with compromised blood vessels or those who are at risk of bleeding.

Moreover, key manufacturers in the industry are prioritizing the development and implementation of digital technologies to enhance knowledge of CRRT among healthcare professionals. For instance, in March 2024 Fresenius Medical Care recently launched an innovative Augmented Reality (AR) application. This cutting-edge technology enables nursing staff to learn Kidney Replacement Therapy in Intensive Care Units more effectively. The AR glasses, paired with digital learning modules, allow nursing staff to gain hands-on experience with acute dialysis machines directly within the intensive care wards. As users interact with the machines, the glasses stream visual and acoustic recordings, providing a comprehensive and immersive learning experience for healthcare professionals.

UK Continuous Renal Replacement Therapy Market Report Highlights

  • The consumables segment dominated the market and accounted for a revenue share of 60.40% in 2023. On the other hand, the consumables segment is expected to register the fastest CAGR during the forecast period owing to growing demand for continuous renal replacement therapy (CRRT) and rising awareness of CRRT benefits.
  • The Continuous Venovenous Hemofiltration (CVVH) segment dominated the market and is also expected to register the fastest CAGR of 10.2% during the forecast period. Manufacturers are providing clinical education and training to healthcare professionals on the use of CVVH technology, which is helping to increase adoption and utilization.
  • England segment dominated the market in 2023 owing to growing cases of AKI. For instance, according to The Renal Association report published in 2023, in 2022, the rate of AKI episodes per million population was 12,651, compared to 11,660 in 2018.
  • Baxter, B. Braun Medical Ltd, Medtronic, Fresenius Medical Care UK Ltd, Braun & Co. Limited, Medica Advanced Technologies Ltd, and NIKKISO UK Co. Ltd. are the key players in the UK Continuous Renal Replacement Therapy (CRRT) market.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. UK Continuous Renal Replacement Therapy Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Prevalence of Acute Kidney Injury (Aki)
3.2.1.2. Rising Awareness of The Importance of Early Treatment
3.2.1.3. Growing Adoption of CRRT In ICUs
3.2.2. Market Restraint Analysis
3.2.2.1. Rising Costs of CRRT Treatment
3.2.2.2. Competition From Alternative Therapies
3.2.3. Market Opportunities Analysis
3.2.3.1. Growing Development of Next-Generation CRRT Devices
3.3. UK Continuous Renal Replacement Therapy Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. UK Continuous Renal Replacement Therapy Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. UK Continuous Renal Replacement Therapy Market Product Movement Analysis
4.3. UK Continuous Renal Replacement Therapy Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. System
4.4.1. System UK Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables UK Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. UK Continuous Renal Replacement Therapy Market: Modality Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. UK Continuous Renal Replacement Therapy Market Modality Movement Analysis
5.3. UK Continuous Renal Replacement Therapy Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
5.4. Slow Continuous Ultra Filtration (SCUF)
5.4.1. Slow Continuous Ultra Filtration (SCUF) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Continuous Venovenous Hemofiltration (CVVH)
5.5.1. Continuous Venovenous Hemofiltration (CVVH) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Continuous Venovenous Hemodialysis (CVVHD)
5.6.1. Continuous Venovenous Hemodialysis (CVVHD) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Continuous Venovenous Hemodiafiltration (CVVHDF)
5.7.1. Continuous Venovenous Hemodiafiltration (CVVHDF) Continuous Renal Replacement Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. UK Continuous Renal Replacement Therapy Market: Regional Estimates & Trend Analysis by Product, By Modality
6.1. Regional Dashboard
6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.3. England
6.3.1. England Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. England
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Scenario
6.3.2.4. Reimbursement Scenario
6.3.2.5. England Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Scotland
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Scenario
6.3.3.4. Reimbursement Scenario
6.3.3.5. Scotland Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Wales
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Scenario
6.3.4.4. Reimbursement Scenario
6.3.4.5. Wales Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Northern Ireland
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Scenario
6.3.5.4. Reimbursement Scenario
6.3.5.5. Northern Ireland Continuous Renal Replacement Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Baxter
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Product Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. B. Braun Medical Ltd
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Product Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Medtronic
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Product Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. Fresenius Medical Care UK Ltd
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Product Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. Braun & Co. Limited
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Medica Advanced Technologies Ltd
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Product Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. NIKKISO UK Co. Ltd.
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Product Benchmarking
7.2.7.4. Strategic Initiatives
7.3. Heat Map Analysis/ Company Market Position Analysis
7.4. Estimated Company Market Share Analysis, 2023
7.5. List of Other Key Market Players
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. UK Continuous Renal Replacement Therapy Market, by Region, 2018 - 2030 (USD Million)
Table 4. UK Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
Table 5. UK Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
Table 6. England Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
Table 7. England Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
Table 8. Scotland Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
Table 9. Scotland Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
Table 10. Wales Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
Table 11. Wales Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
Table 12. Northern Ireland Continuous Renal Replacement Therapy Market, by Product, 2018 - 2030 (USD Million)
Table 13. Northern Ireland Continuous Renal Replacement Therapy Market, by Modality, 2018 - 2030 (USD Million)
Table 14. Participant’s Overview
Table 15. Financial Performance
Table 16. Product Benchmarking
Table 17. Strategic Initiatives
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 UK Continuous Renal Replacement Therapy Market, Market Segmentation
Fig. 7 Market Driver Analysis (Current & Future Impact)
Fig. 8 Market Restraint Analysis (Current & Future Impact)
Fig. 9 Market Opportunity Analysis (Current & Future Impact)
Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 11 Porter’s Five Forces Analysis
Fig. 12 Regional Marketplace: Key Takeaways
Fig. 13 UK Continuous Renal Replacement Therapy Market, for System, 2018 - 2030 (USD Million)
Fig. 14 UK Continuous Renal Replacement Therapy Market, for Consumables, 2018 - 2030 (USD Million)
Fig. 15 UK Continuous Renal Replacement Therapy Market, for Slow Continuous Ultra Filtration (SCUF), 2018 - 2030 (USD Million)
Fig. 16 UK Continuous Renal Replacement Therapy Market, for Continuous Venovenous Hemofiltration (CVVH), 2018 - 2030 (USD Million)
Fig. 17 UK Continuous Renal Replacement Therapy Market, for Continuous Venovenous Hemodialysis (CVVHD), 2018 - 2030 (USD Million)
Fig. 18 UK Continuous Renal Replacement Therapy Market, for Continuous Venovenous Hemodiafiltration (CVVHDF), 2018 - 2030 (USD Million)
Fig. 19 Regional Outlook, 2023 & 2030
Fig. 20 England Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
Fig. 21 Scotland Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
Fig. 22 Wales Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)
Fig. 23 Northern Ireland Continuous Renal Replacement Therapy Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Baxter
  • B. Braun Medical Ltd
  • Medtronic
  • Fresenius Medical Care UK Ltd
  • Braun & Co. Limited
  • Medica Advanced Technologies Ltd
  • NIKKISO UK Co. Ltd.

Methodology

Loading
LOADING...

Table Information